Bleakley Financial Group, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,284 filers reported holding NOVARTIS A G in Q2 2024. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bleakley Financial Group, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q2 2024$6,251,414
+18.1%
58,721
+7.3%
0.18%
+17.6%
Q1 2024$5,294,134
+7.4%
54,731
+12.1%
0.15%
-2.5%
Q4 2023$4,930,167
+7.6%
48,828
+8.6%
0.16%
-2.5%
Q3 2023$4,580,139
+1.6%
44,965
+0.7%
0.16%
+14.2%
Q2 2023$4,506,459
-7.7%
44,658
-15.9%
0.14%
-13.5%
Q1 2023$4,884,818
+12.5%
53,096
+11.0%
0.16%
+5.2%
Q4 2022$4,340,66647,8470.16%
Other shareholders
NOVARTIS A G shareholders Q2 2024
NameSharesValueWeighting ↓
Martin Investment Management, LLC 318,637$27,960,0007.08%
MANAGED ASSET PORTFOLIOS, LLC 417,183$36,608,0005.02%
SAL Trading, LLC 233,600$20,498,0004.77%
SCHARF INVESTMENTS, LLC 1,340,680$117,662,0003.49%
SAL Trading, LLC 155,783$13,670,0003.18%
First Fiduciary Investment Counsel, Inc. 169,371$14,862,0002.90%
PRENTISS SMITH & CO INC 55,026$4,829,0002.90%
GARLAND CAPITAL MANAGEMENT INC 47,630$4,180,0002.77%
Cullen Capital Management, LLC 3,295,271$289,160,0002.66%
WILKINS INVESTMENT COUNSEL INC 133,880$11,748,0002.65%
View complete list of NOVARTIS A G shareholders